BTZ vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BTZ exhibits a stable financial health with a Piotroski F-Score of 6/9, indicating moderate strength, though the absence of an Altman Z-Score limits distress risk assessment. The stock appears undervalued relative to the Graham Number of $16.77 and intrinsic value of $32.45, trading at $10.57, but weak technical trends and declining revenue raise concerns. Exceptionally high profit margins and a 9.5% dividend yield are offset by a high payout ratio and deteriorating liquidity metrics. Relative to peers, BTZ has a lower P/E and higher yield but lags in revenue growth, warranting caution despite apparent value.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BTZ vs JPM: Head-to-Head Comparison
This page compares BlackRock Credit Allocation Income Trust (BTZ) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.